Part,  Chapter, Paragraph

 1   II,     5.  5.  3|    measures for clinical practice (NICE, www k; SIGN, www ). Although
 2   II,     5.  5.  3|        Italiana contro l’Epilessia~NICE~National Institute for Clinical
 3   II,     5. 11.  3|          their parents and carers (NICE clinical guideline).~Surveys
 4   II,     5. 11.  7|           and clinical excellence (NICE) (2007): clinical guideline
 5   II,     9.  2.  3|            of Clinical Excellence (NICE) guidance on prescribing
 6   II,     9.  2.  8|         Measles, Mumps and Rubella~NICE~National Institute of Clinical
 7  III,    10.  6.  2|     conditions, it is obvious that nice, healthy food and housing
 8   IV,    11.Acr    |          HPV~Human Papilloma Virus~NICE~National Institute of Health
 9   IV,    11.  1.  5|           and Clinical Excellence (NICE), are increasingly incorporating
10   IV,    11.  4    |           and Clinical Excellence (NICE) (Walley, 2007) .~ ~The
11   IV,    11.  4    |         HTA Programme supports all NICE technology appraisals by
12   IV,    11.  4    | submissions. These are provided to NICE’s appraisal committees to
13   IV,    11.  4    |            publicly available once NICE has reached its preliminary
14   IV,    11.  6.  4|      Nevertheless, the use of HTA (NICE) is highly developed and